Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Drive AB consortium launched to develop economic models for pharmaceutical industry By PBR Staff Writer
A new European consortium called Driving Reinvestment in research and development and Responsible Antibiotic Use (Drive AB) has been launched, to combat the rising global threat of antibiotic resistance.
Contract Research & Services > Contract Research > News
Cancer Research UK, Leukaemia & Lymphoma Research partner for new blood cancer drugs By PBR Staff Writer
Cancer Research UK through its commercial arm has signed an agreement with Leukaemia & Lymphoma Research (LLR) to co-fund the early-phase human clinical trials of experimental blood cancer drugs.
Contract Research & Services > Contract Research > News Roskamp Institute discovers new target for drugs to treat Alzheimer's disease Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Ophthalmic Study Endpoints
| By Cromsource
Ophthalmic studies rely on complex tests and assessments to meet clinical study endpoints. Each test may be time-consuming to administer, assess, and interpret. Consequently, it is important not to overcrowd a study with unnecessary assessments. Choosing endpoints that are clinically relevant is increasingly important in bringing new therapies to market more quickly.This paper provides a brief overview of some common endpoints in ophthalmology research, and issues to take into account when considering endpoints for ophthalmic studies.
Contract Research & Services > Contract Research > White Papers
Ophthalmology Site Selection
| By Cromsource
Ophthalmology studies use cutting edge technologies and highly technical endpoints. Many assessments involve an understanding of physics and the standardisation of tests across study sites is crucial. Sites must be able to demonstrate that they have excellent experience in managing and conducting ophthalmic research.This paper provides a brief overview of the site selection process and highlights points for consideration when selecting study sites for ophthalmic research.
Contract Research & Services > Contract Research > White Papers
Ophthalmology Site Certification
| By Cromsource
Ophthalmology studies employ technical endpoints requiring specialised capabilities and a detailed understanding of ophthalmic research methods. Correct implementation of the study protocol and consistency of data across sites may be achieved by ensuring that sites and personnel are trained to a high standard and will deploy testing in a consistent manner. Site certification is an important tool used to standardise procedures and add credibility to clinical study data.This paper provides a brief overview of points to consider in site certification for ophthalmology studies.
Contract Research & Services > Contract Research > White Papers
Roskamp Institute discovers new target for drugs to treat Alzheimer's disease
Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Contract Research & Services > Contract Research > News
MPI Research buys Jasper Clinical Research & Development
By PBR Staff Writer
MPI Research has acquired the assets of Jasper Clinical Research & Development, a clinical research organization (CRO) that offers early-stage human clinical testing of new drugs.
Contract Research & Services > Contract Research > News
Bayer, Kyoto University partner on collaborative research projects
By PBR Staff Writer
Bayer HealthCare has signed a two-year collaboration agreement with Kyoto University’s Office of Society-Academia Collaboration for Innovation (KU-SACI) in Japan to jointly discover candidates for possible collaborative research projects.
Contract Research & Services > Contract Research > News
Roche to invest $3.2bn in Basel site development
By PBR Staff Writer
Swiss health-care firm Roche is planning to invest CHF3bn ($3.2bn) over the next ten years on development work at its Basel site, including CHF1.7bn ($1.8bn) on the construction of a new research and development (R&D) centre.
Contract Research & Services > Contract Research > News
Global Biosimilar Development
| By PRA Health Sciences
Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy, and the misconceptions that can arise from misleading published reports.
Contract Research & Services > Contract Research > White Papers
Leading Researchers join Biogen Idec to advance drug discovery for neurodegenerative diseases
Biogen Idec announced that two leading neuroscientists have joined the company to advance its research in neurodegenerative diseases.
Contract Research & Services > Contract Research > News
Global Capabilities in Central Nervous System Research
| By PRA Health Sciences
PRA Health Sciences’ (PRA) Early Development Services (EDS) group has a long-standing track record of early clinical development work in various CNS indications through our global clinical facilities.
Contract Research & Services > Contract Research > White Papers
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250